Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Amphastar Pharmaceuticals posted Q1 results last week that beat the bottom-line consensus. The stock appears cheap at under eight times forward earnings, but the company ...

The Oscar-nominated actress talks about playing the activist whose 1990s lawsuit demanding equal pay with her male colleagues went all the way to the Supreme Court, and how her own mother inspired her ...

While ILCG offers diversified growth exposure, its elevated volatility and lagging performance against top growth funds ...

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...

President Donald Trump's second term in office has been challenging for investors, at least so far. Trump imposed sweeping ...

The stock should perform well beyond 2030 thanks to its impressive innovative abilities. With a constellation of ...

Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...

It's been a while since Clarkson nabbed a movie role as full-scale and invigorating as the one she has in "Lilly," a ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...